Knowledge and attitudes towards influenza and influenza vaccination among pregnant women in Kenya.
Adolescent
Adult
Child
Cross-Sectional Studies
Female
Health Knowledge, Attitudes, Practice
Humans
Influenza Vaccines
Influenza, Human
/ prevention & control
Kenya
Patient Acceptance of Health Care
Pregnancy
Pregnancy Complications, Infectious
/ prevention & control
Pregnant Women
Vaccination
Young Adult
Attitudes
Influenza vaccine
Knowledge
Pregnant women
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
07 10 2020
07 10 2020
Historique:
received:
02
05
2020
revised:
04
08
2020
accepted:
06
08
2020
pubmed:
8
9
2020
medline:
28
4
2021
entrez:
7
9
2020
Statut:
ppublish
Résumé
Influenza vaccination during pregnancy benefits mothers and children. Kenya and other low- and middle-income countries have no official influenza vaccination policies to date but are moving towards issuing such policies. Understanding determinants of influenza vaccine uptake during pregnancy in these settings is important to inform policy decisions and vaccination rollout. We interviewed a convenience sample of women at antenatal care facilities in four counties (Nairobi, Mombasa, Marsabit, Siaya) in Kenya. We described knowledge and attitudes regarding influenza vaccination and assessed factors associated with willingness to receive influenza vaccine. We enrolled 507 pregnant women, median age was 26 years (range 15-43). Almost half (n = 240) had primary or no education. Overall, 369 (72.8%) women had heard of influenza. Among those, 288 (78.1%) believed that a pregnant woman would be protected if vaccinated, 252 (68.3%) thought it was safe to receive a vaccine while pregnant, and 223 (60.4%) believed a baby would be protected if mother was vaccinated. If given opportunity, 309 (83.7%) pregnant women were willing to receive the vaccine. Factors associated with willingness to receive influenza vaccine were mothers' belief in protective effect (OR 3.87; 95% CI 1.56, 9.59) and safety (OR 5.32; 95% CI 2.35, 12.01) of influenza vaccines during pregnancy. Approximately one third of pregnant women interviewed had never heard of influenza. Willingness to receive influenza vaccine was high among women who had heard about influenza. If the Kenyan government recommends influenza vaccine for pregnant women, mitigation of safety concerns and education on the benefits of vaccination could be the most effective strategies to improve vaccine acceptance.
Sections du résumé
BACKGROUND
Influenza vaccination during pregnancy benefits mothers and children. Kenya and other low- and middle-income countries have no official influenza vaccination policies to date but are moving towards issuing such policies. Understanding determinants of influenza vaccine uptake during pregnancy in these settings is important to inform policy decisions and vaccination rollout.
METHODS
We interviewed a convenience sample of women at antenatal care facilities in four counties (Nairobi, Mombasa, Marsabit, Siaya) in Kenya. We described knowledge and attitudes regarding influenza vaccination and assessed factors associated with willingness to receive influenza vaccine.
RESULTS
We enrolled 507 pregnant women, median age was 26 years (range 15-43). Almost half (n = 240) had primary or no education. Overall, 369 (72.8%) women had heard of influenza. Among those, 288 (78.1%) believed that a pregnant woman would be protected if vaccinated, 252 (68.3%) thought it was safe to receive a vaccine while pregnant, and 223 (60.4%) believed a baby would be protected if mother was vaccinated. If given opportunity, 309 (83.7%) pregnant women were willing to receive the vaccine. Factors associated with willingness to receive influenza vaccine were mothers' belief in protective effect (OR 3.87; 95% CI 1.56, 9.59) and safety (OR 5.32; 95% CI 2.35, 12.01) of influenza vaccines during pregnancy.
CONCLUSION
Approximately one third of pregnant women interviewed had never heard of influenza. Willingness to receive influenza vaccine was high among women who had heard about influenza. If the Kenyan government recommends influenza vaccine for pregnant women, mitigation of safety concerns and education on the benefits of vaccination could be the most effective strategies to improve vaccine acceptance.
Identifiants
pubmed: 32893035
pii: S0264-410X(20)31046-X
doi: 10.1016/j.vaccine.2020.08.015
pmc: PMC7526973
pii:
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6832-6838Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Vaccine. 2011 Aug 18;29(36):6136-43
pubmed: 21722689
Influenza Other Respir Viruses. 2018 Jan;12(1):30-37
pubmed: 29243402
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
N Engl J Med. 2014 Sep 4;371(10):918-31
pubmed: 25184864
Clin Infect Dis. 2014 Feb;58(4):449-57
pubmed: 24280090
Vaccine. 2017 Jul 24;35(33):4060-4063
pubmed: 28668569
Influenza Other Respir Viruses. 2019 Mar;13(2):138-147
pubmed: 30596225
J Reprod Med. 2013 Sep-Oct;58(9-10):383-8
pubmed: 24050026
Vaccine. 2012 Jun 13;30(28):4200-8
pubmed: 22537991
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S67-74
pubmed: 22920063
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
PLoS One. 2015 Sep 17;10(9):e0138272
pubmed: 26379030
Open Forum Infect Dis. 2017 Feb 10;4(1):ofw262
pubmed: 28480255
Saudi Pharm J. 2017 Jan;25(1):76-82
pubmed: 28223865
BJGP Open. 2018 Aug 08;2(3):bjgpopen18X101599
pubmed: 30564732
Pediatr Infect Dis J. 2014 Sep;33(9):912-9
pubmed: 24577042
Vaccine. 2014 Nov 20;32(49):6649-54
pubmed: 25280436
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S33-7
pubmed: 22920057
Geburtshilfe Frauenheilkd. 2017 Apr;77(4):340-351
pubmed: 28552997
PLoS Curr. 2015 Feb 25;7:
pubmed: 25789203
PLoS One. 2014 Jun 23;9(6):e98615
pubmed: 24955962
Bull World Health Organ. 2012 Nov 1;90(11):822-30
pubmed: 23226894
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S141-8
pubmed: 21492825
Vaccine. 2014 Aug 6;32(36):4602-13
pubmed: 24996123
Med J Aust. 2013 Apr 15;198(7):373-5
pubmed: 23581957
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
Vaccine. 2016 Apr 19;34(18):2141-6
pubmed: 26854910
Clin Infect Dis. 2012 Oct;55(7):996-1003
pubmed: 22715173
BMC Infect Dis. 2017 Jan 9;17(1):48
pubmed: 28068918
MMWR Morb Mortal Wkly Rep. 2011 Aug 26;60(33):1128-32
pubmed: 21866086
Vaccine. 2018 Aug 28;36(36):5379-5384
pubmed: 28822646
Am J Prev Med. 2017 Dec;53(6):845-853
pubmed: 28867143
Vaccine. 2013 Jun 12;31(27):2874-8
pubmed: 23623863
BMC Infect Dis. 2015 Jan 27;15:26
pubmed: 25623944
J Infect Dis. 2012 Dec 15;206 Suppl 1:S14-21
pubmed: 23169960
Adv Prev Med. 2012;2012:932741
pubmed: 23082253
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552
Vaccine. 2013 Oct 25;31(45):5281-8
pubmed: 24016814
Obstet Gynecol. 2018 Apr;131(4):e109-e114
pubmed: 29578985